Impax Asset Management Group plc acquired a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 10,704 shares of the company’s stock, valued at approximately $1,285,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. American National Bank & Trust boosted its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. NewSquare Capital LLC lifted its holdings in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after buying an additional 193 shares during the period. Ransom Advisory Ltd purchased a new stake in shares of Clorox in the first quarter worth about $35,000. Hantz Financial Services Inc. purchased a new stake in shares of Clorox in the second quarter worth about $31,000. Finally, GW&K Investment Management LLC grew its holdings in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after acquiring an additional 208 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on CLX shares. JPMorgan Chase & Co. decreased their price target on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. Rothschild & Co Redburn decreased their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Jefferies Financial Group reissued a “buy” rating and set a $152.00 price target on shares of Clorox in a report on Tuesday, November 4th. TD Cowen dropped their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research report on Wednesday, October 1st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, Clorox presently has an average rating of “Reduce” and an average target price of $125.69.
Clorox Stock Performance
Shares of NYSE:CLX opened at $104.20 on Friday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The business’s 50 day moving average price is $118.14 and its 200-day moving average price is $123.98. The firm has a market capitalization of $12.71 billion, a PE ratio of 15.98, a P/E/G ratio of 0.92 and a beta of 0.52. The Clorox Company has a 1 year low of $104.08 and a 1 year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue was down 18.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date was Wednesday, October 22nd. Clorox’s dividend payout ratio is 77.86%.
Insider Buying and Selling at Clorox
In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.63% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Stock Market Sectors: What Are They and How Many Are There?
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- The Most Important Warren Buffett Stock for Investors: His Own
- Ondas Holdings Signals a Rebound as Drone Demand Soars
- What is a Secondary Public Offering? What Investors Need to Know
- Disney’s 2026 Outlook Brightens Under Iger’s Magic Touch
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
